Ian Garland
Director/Board Member at Ligand UK Development Ltd.
Profile
Ian Garland is currently a Director at Ligand UK Development Ltd.
He was previously the Chief Executive Officer & Executive Director at Ligand UK Ltd.
from 2012 to 2018.
He was also the Chief Executive Officer at Acambis Plc in 2007, and a Director at Vernalis (R&D) Ltd.
from 2009 to 2018.
Additionally, he was the Chief Financial Officer at Amarin Corp.
Plc in 2003, and a Principal at KPMG LLP from 1988 to 1995.
He was also a Principal at Pepsi-Cola North America from 1995 to 1999, and a Chief Financial Officer at Arrow Therapeutics Ltd.
from 2004 to 2007.
Furthermore, he was a Principal at Medeva Plc from 1995 to 1999, and the President & Chief Operating Officer at Celltech Pharma Europe Ltd.
Ian Garland active positions
| Companies | Position | Start |
|---|---|---|
Ligand UK Development Ltd.
 Ligand UK Development Ltd. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Ligand UK Development Ltd. is a private company that manufactures pharmaceutical products. The company is based in Winnersh, UK. | Director/Board Member | - |
Former positions of Ian Garland
| Companies | Position | End |
|---|---|---|
| VERNALIS | Chief Executive Officer | 2018-10-11 |
Vernalis (R&D) Ltd.
 Vernalis (R&D) Ltd. Pharmaceuticals: MajorHealth Technology Vernalis (R&D) Ltd. engages in the research development of biotechnology and pharmaceutical products manufacturing. The company was founded on February 4, 1986 and is headquartered in Wokingham, the United Kingdom. | Director/Board Member | 2018-10-11 |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | President | 2008-08-31 |
Arrow Therapeutics Ltd.
 Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Director of Finance/CFO | 2006-12-31 |
| AMARIN CORPORATION PLC | Director of Finance/CFO | 2003-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AMARIN CORPORATION PLC | Health Technology |
| NOVARTIS AG | Health Technology |
| Private companies | 9 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1986 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
Pepsi-Cola North America
 Pepsi-Cola North America Beverages: Non-AlcoholicConsumer Non-Durables Pepsi-Cola North America manufactures and markets beverage products. It offers soft drinks, bottled waters, iced teas, juices, and sports drinks. The company is headquartered in Purchase, NY | Consumer Non-Durables |
Arrow Therapeutics Ltd.
Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Medeva Plc | Health Technology |
Ligand UK Development Ltd.
Ligand UK Development Ltd. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Ligand UK Development Ltd. is a private company that manufactures pharmaceutical products. The company is based in Winnersh, UK. | Health Technology |
Vernalis (R&D) Ltd.
Vernalis (R&D) Ltd. Pharmaceuticals: MajorHealth Technology Vernalis (R&D) Ltd. engages in the research development of biotechnology and pharmaceutical products manufacturing. The company was founded on February 4, 1986 and is headquartered in Wokingham, the United Kingdom. | Health Technology |
| Celltech Pharma Europe Ltd. |
- Stock Market
- Insiders
- Ian Garland
